Exelixis Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Deciphera Pharmaceuticals and Glactone Pharma.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Glactone Pharma Glactone Pharma is a biotech company. It develops a pipeline of STAT3 inhibitors for the use in immuno-oncology and for the treatment of drug-resistant cancers. | ||
Founding Date | Founding Date 1994 | Founding Date 2003 | Founding Date 2012 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Alameda, US HQ | Locations Waltham, US HQ Lawrence, US | Locations Helsingborg, SE HQ |
Employees | Employees 1,14712% decrease | Employees 35037% increase | Employees 6 |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $3.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit $159.6m (FY, 2023) | Gross profit N/A |
Net income | Net income $782.6m (FY, 2025) | Net income ($194.9m) (FY, 2023) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyGlactone Pharma
HQ
Helsingborg, SE
Glactone Pharma is a biotech company. It develops a pipeline of STAT3 inhibitors for the use in immuno-oncology and for the treatment of drug-resistant cancers.
View company